Found 65 matching trials
Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
PHASE1This is a phase 1 study of the drug dacomitinib with radiotherapy, with or ...
Location
Princess Margaret Cancer Centre
A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer
PHASE2This is a Phase 2 study of oral dacomitinib given every 12 hours over days ...
Location
Tower Hematology Oncology Medical Group
Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
PHASE1To identify a dose of dacomitinib in combination with pemetrexed that is sa...
Location
Medizinische Universität Graz Klinische Abteilung für Onkologie
A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
NAThis is a study to assess how much of the investigational drug, PF-00298804...
Location
Princess Margaret Hospital
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.
N/AThe purpose of this study is to learn about dacomitinib for the possible tr...
Location
Multiple Locations
Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer
PHASE2This is an open label, monocentric, uncontrolled phase II trial with Dacomi...
Location
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804
PHASE1The study will determine if bioequivalence can be claimed between the propo...
Location
Pfizer Investigational Site
PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma
PHASE2Epidermal growth factor receptor (EGFR) is often over-expressed, and have b...
Location
Severance Hospital
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PHASE2There are three arms to this study (A, B and C) The purpose of this researc...
Location
Massachusetts General Hospital
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
PHASE1This is a multicenter, open label, Phase I/IIB study investigating the effi...
Location
Shanghai Chest Hospital